DMH25 is a novel, covalent, and potent mTOR inhibitor. It demonstrates significant antitumor efficacy in vivo, particularly against triple-negative breast cancer models. This small molecule is a valuable research tool for studying mTOR signaling and oncology in both cellular and animal studies.
Molekulargewicht:
489.94
Reinheit:
99.26% (May vary between batches)
CAS Nummer:
[1685280-21-0]
Formel:
C15H8Br3NO3
Target-Kategorie:
mTOR
Anwendungsbeschreibung:
Solubility: DMSO:25 mg/mL (51.03 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten